Quince Therapeutics Inc [NASDAQ: QNCX] closed the trading session at $1.31.
The stocks have a year to date performance of 24.76 percent and weekly performance of 50.57 percent. The stock has been moved at 31.87 percent over the last six months. The stock has performed 69.03 percent around the most recent 30 days and changed 76.12 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 297.36K shares, QNCX reached to a volume of 12476481 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Quince Therapeutics Inc [QNCX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QNCX shares is $11.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QNCX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Quince Therapeutics Inc is set at 0.15 The Price to Book ratio for the last quarter was 1.21, with the Price to Cash per share for the same quarter was set at 1.37.
QNCX stock trade performance evaluation
Quince Therapeutics Inc [QNCX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 50.57. With this latest performance, QNCX shares gained by 69.03% in over the last four-week period, additionally plugging by 31.87% over the last 6 months – not to mention a rise of 34.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QNCX stock in for the last two-week period is set at 73.22, with the RSI for the last a single of trading hit 75.58, and the three-weeks RSI is set at 71.06 for Quince Therapeutics Inc [QNCX]. The present Moving Average for the last 50 days of trading for this stock 0.7846, while it was recorded at 1.1503 for the last single week of trading, and 0.9276 for the last 200 days.
Quince Therapeutics Inc [QNCX]: An insightful look at the core fundamentals
Quince Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.15 and a Current Ratio set at 6.15.
Earnings per share (EPS) analysis for Quince Therapeutics Inc [QNCX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QNCX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Quince Therapeutics Inc go to 18.30%.
Quince Therapeutics Inc [QNCX]: Institutional Ownership
There are presently around $25.24%, or 29.27%% of QNCX stock, in the hands of institutional investors.